Show results for
Refine by
Locations
- Europe
- Albania
- Andorra
- Austria
- Belarus
- Belgium
- Bosnia & Herzegovina
- Bulgaria
- Croatia
- Cyprus
- Czech Republic
- Denmark
- Estonia
- Faroe Islands
- Finland
- France
- Germany
- Greece
- Hungary
- Iceland
- Ireland
- Italy
- Kosovo
- Latvia
- Liechtenstein
- Lithuania
- Luxembourg
- Macedonia
- Malta
- Moldova
- Monaco
- Montenegro
- Netherlands
- Northern Ireland
- Norway
- Poland
- Portugal
- Romania
- San Marino
- Serbia
- Slovakia
- Slovenia
- Spain
- Sweden
- Switzerland
- Turkey
- Ukraine
- United Kingdom
- Vatican City
Disease Early Services In Europe
5 services found
by:Quy Technology Pvt Ltd based inGurgaon (Delhi NCR), INDIA
AI Recommendation engines today play an important role in helping businesses and customers have a better user experience. Product recommendations, movie suggestions, and people whom you would like to know on social media platforms are some of the popular examples of AI recommendation systems. With Quytech’s recommendation engine or system development services, we empower your business to ...
by:Hummingbird Diagnostics GmbH based inHeidelberg, GERMANY
Non-invasive sample sources as key for early disease detection & therapeutic monitoring body fluids, including whole blood, serum, plasma, CSF, urine optimized and validated ...
by:Oncimmune Holdings PLC based inNottingham, UNITED KINGDOM
Autoimmune disease is caused by the breaking of self-tolerance. Oncimmune’s understanding of the immune system as a mediator of disease powers the ImmunoINSIGHTS service for autoimmune ...
Manufactured by:CENTOGENE N.V. based inRostock, GERMANY
CentoICU – Genetic Testing When Every Moment Counts. Up to one-third of all babies and children admitted to the ICU have a genetic disease. For many patients, early identification can make a difference in their immediate and long-term ...
Manufactured by:Soteria Medical BV based inArnhem, NETHERLANDS
Prostate cancer is the most common cancer, other than non-melanoma skin cancer, and the second leading cause of cancer-related death in men in the United States. Prostate cancer incidence rates rose dramatically in the late 1980s, when screening with the prostate-specific antigen (PSA) test, which received initial U.S. Food and Drug Administration approval in 1986, came into wide use. It is ...